Ocugen Announces Appointment of Marna C. Whittington, PhD, to Board of Directors
23 mars 2022 07h44 HE
|
Ocugen
MALVERN, Pa., March 23, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel gene therapies,...
Ocugen, Inc. Appoints Jessica Crespo, CPA, to Chief Accounting Officer and Senior Vice President, Finance
21 mars 2022 18h36 HE
|
Ocugen
MALVERN, Pa., March 21, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to...
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 mars 2022 17h56 HE
|
Ocugen
MALVERN, Pa., March 18, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness...
Ocugen Inc. Announces Nirdosh Jagota, Ph.D. as Senior Vice President, Regulatory Affairs, Compliance & Safety
24 janv. 2022 07h12 HE
|
Ocugen
MALVERN, Pa., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness...
Ocugen, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21 janv. 2022 18h12 HE
|
Ocugen
MALVERN, Pa., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness...
Ocugen, Inc. to Present at Upcoming H.C. Wainwright Bioconnect Conference
06 janv. 2022 18h03 HE
|
Ocugen
MALVERN, Pa., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness...
OCGN FINAL DEADLINE TODAY: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 17 Deadline in Securities Class Action – OCGN
17 août 2021 09h19 HE
|
The Rosen Law Firm PA
NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2021...
DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
16 août 2021 11h40 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Los Angeles -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – OCGN
11 août 2021 19h47 HE
|
The Rosen Law Firm PA
NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2021 and...
DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
09 août 2021 11h30 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...